Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

RIGL Rigel Pharmaceuticals Inc

0,968

0,0176 (1,85%)

Nach Börsenschluss

Zuletzt aktualisiert: 23:45:02

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Rigel Pharmaceuticals Charts.

News Rigel Pharmaceuticals Inc

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
Dienstag 7 Mai 2024 (2 Wochen vor) • PR Newswire (US)

Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update
Dienstag 30 April 2024 (3 Wochen vor) • PR Newswire (US)

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Mittwoch 10 April 2024 (1 Monat vor) • PR Newswire (US)

Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma
Donnerstag 4 April 2024 (2 Monate vor) • PR Newswire (US)

Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
Dienstag 12 März 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Dienstag 5 März 2024 (2 Monate vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Rigel Pharmaceuticals Inc News-Artikel

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen